671 related articles for article (PubMed ID: 17014394)
1. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
Mathieu C
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
[TBL] [Abstract][Full Text] [Related]
2. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
Pham DQ; Cohen H; Chu V
J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
[TBL] [Abstract][Full Text] [Related]
3. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term.
Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235
[TBL] [Abstract][Full Text] [Related]
4. [Perspectives of inhaled insulin treatment].
Chodorowski Z; Sein Anand J
Przegl Lek; 2007; 64(4-5):365-7. PubMed ID: 17724916
[TBL] [Abstract][Full Text] [Related]
5. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of patients with diabetes mellitus by means of inhaled insulin].
Simsek S; de Galan BE; Tack CJ; Heine RJ
Ned Tijdschr Geneeskd; 2006 Apr; 150(15):829-32. PubMed ID: 16676511
[TBL] [Abstract][Full Text] [Related]
8. A review of inhaled technosphere insulin.
Neumiller JJ; Campbell RK; Wood LD
Ann Pharmacother; 2010; 44(7-8):1231-9. PubMed ID: 20516362
[TBL] [Abstract][Full Text] [Related]
9. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes.
Skyler JS; Jovanovic L; Klioze S; Reis J; Duggan W;
Diabetes Care; 2007 Mar; 30(3):579-85. PubMed ID: 17327324
[TBL] [Abstract][Full Text] [Related]
10. Inhaled insulin (exubera).
Med Lett Drugs Ther; 2006 Jul; 48(1239):57-8. PubMed ID: 16841019
[No Abstract] [Full Text] [Related]
11. Inhaled insulin: Exubera.
Odegard PS; Capoccia KL
Ann Pharmacother; 2005 May; 39(5):843-53. PubMed ID: 15827072
[TBL] [Abstract][Full Text] [Related]
12. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
13. First inhaled insulin product approved.
FDA Consum; 2006; 40(2):28-9. PubMed ID: 16671198
[TBL] [Abstract][Full Text] [Related]
14. Inhaled insulin delivery--where are we now?
Muchmore DB; Gates JR
Diabetes Obes Metab; 2006 Nov; 8(6):634-42. PubMed ID: 17026487
[TBL] [Abstract][Full Text] [Related]
15. [Inhaled insulin: clinical results in type 2 diabetic patients].
Selam JL
Diabetes Metab; 2001 Nov; 27(5 Pt 3):S28-32. PubMed ID: 11910977
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial.
Raskin P; Heller S; Honka M; Chang PC; Boss AH; Richardson PC; Amin N
Diabetes Obes Metab; 2012 Feb; 14(2):163-73. PubMed ID: 21951325
[TBL] [Abstract][Full Text] [Related]
17. Inhaled dry powder insulin for the treatment of diabetes mellitus.
Setter SM; Levien TL; Iltz JL; Odegard PS; Neumiller JJ; Baker DE; Campbell RK
Clin Ther; 2007 May; 29(5):795-813. PubMed ID: 17697900
[TBL] [Abstract][Full Text] [Related]
18. Inhaled insulin--does it become reality?
Siekmeier R; Scheuch G
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():81-113. PubMed ID: 19218634
[TBL] [Abstract][Full Text] [Related]
19. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: safety.
Brain JD
Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S14-8. PubMed ID: 16135134
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of inhaled insulin (AERx iDMS) compared with subcutaneous insulin therapy in patients with Type 1 diabetes: 1-year data from a randomized, parallel group trial.
Moses RG; Bartley P; Lunt H; O'Brien RC; Donnelly T; Gall MA; Vesterager A; Wollmer P; Roberts A
Diabet Med; 2009 Mar; 26(3):260-7. PubMed ID: 19317821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
